SK1912004A3 - Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome - Google Patents
Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome Download PDFInfo
- Publication number
- SK1912004A3 SK1912004A3 SK191-2004A SK1912004A SK1912004A3 SK 1912004 A3 SK1912004 A3 SK 1912004A3 SK 1912004 A SK1912004 A SK 1912004A SK 1912004 A3 SK1912004 A3 SK 1912004A3
- Authority
- SK
- Slovakia
- Prior art keywords
- carbon atoms
- alkyl
- group
- tricyclo
- aza
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33481001P | 2001-10-31 | 2001-10-31 | |
| US33585801P | 2001-11-26 | 2001-11-26 | |
| PCT/IB2002/004379 WO2003037329A1 (fr) | 2001-10-31 | 2002-10-21 | Agonistes du recepteur d'acetylcholine nicotinique pour traiter les impatiences des membres inferieurs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK1912004A3 true SK1912004A3 (en) | 2004-09-08 |
Family
ID=26989404
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK191-2004A SK1912004A3 (en) | 2001-10-31 | 2002-10-21 | Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1439836A1 (fr) |
| JP (1) | JP2005507411A (fr) |
| KR (1) | KR20050038583A (fr) |
| CN (1) | CN1568184A (fr) |
| BR (1) | BR0213696A (fr) |
| CA (1) | CA2460118A1 (fr) |
| CZ (1) | CZ2004524A3 (fr) |
| HU (1) | HUP0401967A2 (fr) |
| IL (1) | IL160967A0 (fr) |
| MX (1) | MXPA04002539A (fr) |
| PL (1) | PL370549A1 (fr) |
| SK (1) | SK1912004A3 (fr) |
| TW (1) | TW200300139A (fr) |
| WO (1) | WO2003037329A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006528237A (ja) * | 2003-05-20 | 2006-12-14 | ファイザー・プロダクツ・インク | バレニクリンの医薬組成物 |
| MXPA06003043A (es) | 2003-09-17 | 2006-05-31 | Xenoport Inc | Tratamiento o prevencion del sindrome piernas inquietas utilizando prodrogas de analogos gaba. |
| CA2622755C (fr) | 2005-10-07 | 2017-01-31 | Exelixis, Inc. | Azetidines en tant qu'inhibiteurs de mek |
| EP2101759B1 (fr) | 2006-12-14 | 2018-10-10 | Exelixis, Inc. | Procédés d'utilisation d'inhibiteurs de mek |
| ES2880399T3 (es) | 2012-07-27 | 2021-11-24 | Neurodyn Life Sciences Inc | Biodisponibilidad cerebral mejorada de galantamina mediante formulaciones seleccionadas y administración transmucosa de profármacos lipofílicos |
| HK1206242A1 (en) * | 2012-07-27 | 2016-01-08 | 神经动力生命科学公司 | Enhanced brain bioavailability of galantamine by selected formulations and transmucosal administration of lipophilic prodrugs |
| GEP201706690B (en) | 2012-10-12 | 2017-06-26 | Exelixis Inc | Novel process for making compounds for use in treatment of cancer |
| US10568852B2 (en) * | 2015-05-22 | 2020-02-25 | Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) | Combination compositions and their use in methods for treating obesity and obesity-related disorders |
| WO2018236957A1 (fr) * | 2017-06-20 | 2018-12-27 | Nexien Biopharma, Inc. | Procédé et compositions permettant de traiter le syndrome des jambes sans repos |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020335A (en) * | 1997-02-06 | 2000-02-01 | Pfizer Inc | (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| US5977131A (en) * | 1997-04-09 | 1999-11-02 | Pfizer Inc. | Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents |
| US6605610B1 (en) * | 1997-12-31 | 2003-08-12 | Pfizer Inc | Aryl fused azapolycyclic compounds |
| EP0955301A3 (fr) * | 1998-04-27 | 2001-04-18 | Pfizer Products Inc. | Dérivés de 7-aza-bicyclo[2.2.1]-heptane, leur préparation et utilisation sur la base d'affinité pour les recepteurs de l'acetylcholine nicotinique neuronaux |
| KR100420423B1 (ko) * | 1998-04-29 | 2004-03-04 | 화이자 프로덕츠 인코포레이티드 | 아릴 축합된 아자 다환식 화합물 |
-
2002
- 2002-10-21 SK SK191-2004A patent/SK1912004A3/sk not_active Application Discontinuation
- 2002-10-21 HU HU0401967A patent/HUP0401967A2/hu unknown
- 2002-10-21 EP EP02802239A patent/EP1439836A1/fr not_active Withdrawn
- 2002-10-21 MX MXPA04002539A patent/MXPA04002539A/es unknown
- 2002-10-21 CN CNA028200292A patent/CN1568184A/zh active Pending
- 2002-10-21 WO PCT/IB2002/004379 patent/WO2003037329A1/fr not_active Ceased
- 2002-10-21 JP JP2003539673A patent/JP2005507411A/ja active Pending
- 2002-10-21 PL PL02370549A patent/PL370549A1/xx not_active Application Discontinuation
- 2002-10-21 BR BR0213696-1A patent/BR0213696A/pt not_active IP Right Cessation
- 2002-10-21 KR KR1020047006544A patent/KR20050038583A/ko not_active Ceased
- 2002-10-21 CA CA002460118A patent/CA2460118A1/fr not_active Abandoned
- 2002-10-21 IL IL16096702A patent/IL160967A0/xx unknown
- 2002-10-21 CZ CZ2004524A patent/CZ2004524A3/cs unknown
- 2002-10-30 TW TW091132199A patent/TW200300139A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050038583A (ko) | 2005-04-27 |
| IL160967A0 (en) | 2004-08-31 |
| PL370549A1 (en) | 2005-05-30 |
| HUP0401967A2 (hu) | 2005-01-28 |
| EP1439836A1 (fr) | 2004-07-28 |
| CA2460118A1 (fr) | 2003-05-08 |
| MXPA04002539A (es) | 2004-05-31 |
| CN1568184A (zh) | 2005-01-19 |
| TW200300139A (en) | 2003-05-16 |
| WO2003037329A1 (fr) | 2003-05-08 |
| CZ2004524A3 (cs) | 2004-07-14 |
| JP2005507411A (ja) | 2005-03-17 |
| BR0213696A (pt) | 2004-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100435611B1 (ko) | 에피나스틴을포함하는동통치료용약제학적조성물 | |
| JP5666910B2 (ja) | 認知機能障害を治療するためのキット、組成物、製品もしくは医薬 | |
| JP2003530345A (ja) | 急性、慢性疼痛及び／またはニューロパシー性疼痛及び片頭痛の治療のための医薬組成物 | |
| TWI224102B (en) | Serotonergic agents | |
| JP2004511512A (ja) | 認識障害の治療のためのアセチルコリンエステラーゼ阻害薬およびｇａｂａａ反作用薬の組合せ使用 | |
| OA12554A (en) | Use of GABA a inverse agonists in combination withnicotine receptor partial agonists, estrogen, sel ective estrogen modulators, or bitamin E for the treatment of cognitive disorders. | |
| RU2003103291A (ru) | Ингибиторы медьсодержащих аминооксидаз | |
| EA019354B1 (ru) | Применение димирацетама для лечения хронической боли | |
| KR20010050225A (ko) | 포유동물에서의 니코틴 탐닉의 예방 및 치료를 위한 약학조성물 | |
| SK1912004A3 (en) | Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome | |
| CN118843624A (zh) | 结晶的咪唑并[4,5-b]吡啶化合物、药物组合物以及它们在治疗医学病况中的应用 | |
| JPH02138214A (ja) | 不安を治療する方法 | |
| WO2002051440A1 (fr) | Medicaments de combinaison | |
| US20030134844A1 (en) | Nicontinic acetylcholine receptor antagonists in the treatment of restless legs syndrome | |
| RU2258506C2 (ru) | Лекарственные средства для предупреждения и лечения нейродегенеративных заболеваний | |
| AU649953B2 (en) | Tetrahydroisoquinolinylcarbamates of 1,2,3,3A,8,8A-hexahydro-1,3A,8-trimethylpyrrolo(2,3-B)indole | |
| US20080312253A1 (en) | Pharmaceutical compositions containing pyrazole derivatives for treating as serotonin antagonist | |
| JP2008512440A (ja) | ジアザビシクロ化合物含有ベンゾイソオキサゾールを用いる気分障害の治療方法 | |
| JP2002249432A (ja) | 併用剤 | |
| KR20020090152A (ko) | 우울증 또는 불안증을 위한 배합 치료 | |
| AU2002363188A1 (en) | Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome | |
| JPWO2000032192A1 (ja) | 医 薬 | |
| KR20010039569A (ko) | 신규의 7-아미노피리도[2,3-디이]피리미딘 유도체 | |
| JPWO1990015607A1 (ja) | 脳機能改善薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC9A | Refused patent application |